Edgar B. Cale - 10 Feb 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
GC and Corporate Secretary
Signature
/s/ Edgar Cale
Issuer symbol
PASG
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:47:28 UTC
Next filing
01 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PASG Common Stock 4,759 10 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Stock Option (right to buy) Award $0 +106,000 $0.000000 106,000 10 Feb 2022 Common Stock 106,000 $4.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2020 Employee Stock Purchase Plan purchases of 1,555 shares that occurred since the date of the Reporting Person's last ownership report.
F2 The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.